Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-Induced Nausea and Vomiting (MK-0517-031)

Clinical trial NCT01594749 · COMPLETED

Trial details

NCT number: NCT01594749
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chemotherapy-Induced Nausea and Vomiting (CINV)

Start date: 2012-09-24
Primary completion: 2014-11-03
Enrollment: 1015

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.